Trial · NCT00481091
Adverse event totals30
The totals the trial posted for each group.
1 to 20 of 30
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Navitoclax 14/21 Day Cycle: 10 mg | 0 | 3 |
| Total, all-cause mortality | Navitoclax 14/21 Day Cycle: 110 mg | 1 | 6 |
| Total, all-cause mortality | Navitoclax 14/21 Day Cycle: 200 mg | 0 | 3 |
| Total, all-cause mortality | Navitoclax 14/21 Day Cycle: 250 mg | 0 | 3 |
| Total, all-cause mortality | Navitoclax 21/21 Day Cycle: 125 mg | 1 | 3 |
| Total, all-cause mortality | Navitoclax 21/21 Day Cycle: 200 mg | 0 | 4 |
| Total, all-cause mortality | Navitoclax 21/21 Day Cycle: 250 mg | 0 | 3 |
| Total, all-cause mortality | Navitoclax 21/21 Day Cycle: 300 mg | 0 | 4 |
| Total, all-cause mortality | Phase 2: Navitoclax 100 mg | 1 | 4 |
| Total, all-cause mortality | Phase 2: Navitoclax 250 mg | 8 | 27 |
| Total, other adverse events | Navitoclax 14/21 Day Cycle: 10 mg | 3 | 3 |
| Total, other adverse events | Navitoclax 14/21 Day Cycle: 110 mg | 6 | 6 |
| Total, other adverse events | Navitoclax 14/21 Day Cycle: 200 mg | 3 | 3 |
| Total, other adverse events | Navitoclax 14/21 Day Cycle: 250 mg | 3 | 3 |
| Total, other adverse events | Navitoclax 21/21 Day Cycle: 125 mg | 3 | 3 |
| Total, other adverse events | Navitoclax 21/21 Day Cycle: 200 mg | 4 | 4 |
| Total, other adverse events | Navitoclax 21/21 Day Cycle: 250 mg | 3 | 3 |
| Total, other adverse events | Navitoclax 21/21 Day Cycle: 300 mg | 4 | 4 |
| Total, other adverse events | Phase 2: Navitoclax 100 mg | 4 | 4 |
| Total, other adverse events | Phase 2: Navitoclax 250 mg | 27 | 27 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00481091/event-totals